Surgical outcomes of the Ex-PRESS glaucoma filtration device in African American and white glaucoma patients

Sarwat Salim, Haiming Du, Sumalee Boonyaleephan, Jim Wan

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Purpose: To compare the surgical outcomes of the Ex-PRESS glaucoma filtration device in African American and white glaucoma patients. Design: Retrospective comparative case series. Methods: This was a comparative case series of 36 eyes of 36 African Americans and 43 eyes of 43 whites that underwent placement of the Ex-PRESS glaucoma filtration device under a partial-thickness scleral flap for uncontrolled glaucoma. All eyes received intraoperative mitomycin C. The primary outcome measures were intraocular pressure (IOP), number of postoperative glaucoma medications, and surgical success. Surgical success was defined as IOP between 5 and 18 mm Hg, with or without glaucoma medications, without further glaucoma surgery, or loss of light perception vision. Results: Average follow-up was 31.9 ± 9.8 (range, 14.6-47) months for African Americans and 30.7 ± 8.6 (range, 14.3-47) months for whites. At 33 months, surgical success was 80.0% in the African American group and 83.3% in the white group (P = 1.00). Reasons for surgical failure included increased IOP (3 eyes, 3.8%), persistent hypotony with maculopathy (1 eye, 1.3%), and further surgery (4 eyes, 5.06%). Compared with preoperative values, the mean postoperative IOP and number of glaucoma medications were significantly reduced in both groups, and no statistical difference was observed between the two groups at 33 months. Postoperative complications were similar in the two groups. Conclusions: Similar surgical outcomes were observed in African American and white glaucoma patients after implantation of the Ex-PRESS glaucoma filtration device. This latest modification of glaucoma filtration surgery may be a better surgical option for African Americans given its potential advantages of no tissue removal, predictable outcomes related to consistent lumen size and controlled flow, fewer postoperative complications, and overall reduced inflammation.

Original languageEnglish (US)
Pages (from-to)955-962
Number of pages8
JournalClinical Ophthalmology
Volume6
Issue number1
DOIs
StatePublished - Jun 21 2012

Fingerprint

African Americans
Glaucoma
Equipment and Supplies
Intraocular Pressure
Filtering Surgery
Mitomycin
Outcome Assessment (Health Care)
Inflammation
Light

All Science Journal Classification (ASJC) codes

  • Ophthalmology

Cite this

Surgical outcomes of the Ex-PRESS glaucoma filtration device in African American and white glaucoma patients. / Salim, Sarwat; Du, Haiming; Boonyaleephan, Sumalee; Wan, Jim.

In: Clinical Ophthalmology, Vol. 6, No. 1, 21.06.2012, p. 955-962.

Research output: Contribution to journalArticle

Salim, Sarwat ; Du, Haiming ; Boonyaleephan, Sumalee ; Wan, Jim. / Surgical outcomes of the Ex-PRESS glaucoma filtration device in African American and white glaucoma patients. In: Clinical Ophthalmology. 2012 ; Vol. 6, No. 1. pp. 955-962.
@article{f240437767794758906d61253ae3849a,
title = "Surgical outcomes of the Ex-PRESS glaucoma filtration device in African American and white glaucoma patients",
abstract = "Purpose: To compare the surgical outcomes of the Ex-PRESS glaucoma filtration device in African American and white glaucoma patients. Design: Retrospective comparative case series. Methods: This was a comparative case series of 36 eyes of 36 African Americans and 43 eyes of 43 whites that underwent placement of the Ex-PRESS glaucoma filtration device under a partial-thickness scleral flap for uncontrolled glaucoma. All eyes received intraoperative mitomycin C. The primary outcome measures were intraocular pressure (IOP), number of postoperative glaucoma medications, and surgical success. Surgical success was defined as IOP between 5 and 18 mm Hg, with or without glaucoma medications, without further glaucoma surgery, or loss of light perception vision. Results: Average follow-up was 31.9 ± 9.8 (range, 14.6-47) months for African Americans and 30.7 ± 8.6 (range, 14.3-47) months for whites. At 33 months, surgical success was 80.0{\%} in the African American group and 83.3{\%} in the white group (P = 1.00). Reasons for surgical failure included increased IOP (3 eyes, 3.8{\%}), persistent hypotony with maculopathy (1 eye, 1.3{\%}), and further surgery (4 eyes, 5.06{\%}). Compared with preoperative values, the mean postoperative IOP and number of glaucoma medications were significantly reduced in both groups, and no statistical difference was observed between the two groups at 33 months. Postoperative complications were similar in the two groups. Conclusions: Similar surgical outcomes were observed in African American and white glaucoma patients after implantation of the Ex-PRESS glaucoma filtration device. This latest modification of glaucoma filtration surgery may be a better surgical option for African Americans given its potential advantages of no tissue removal, predictable outcomes related to consistent lumen size and controlled flow, fewer postoperative complications, and overall reduced inflammation.",
author = "Sarwat Salim and Haiming Du and Sumalee Boonyaleephan and Jim Wan",
year = "2012",
month = "6",
day = "21",
doi = "10.2147/OPTH.S32282",
language = "English (US)",
volume = "6",
pages = "955--962",
journal = "Clinical Ophthalmology",
issn = "1177-5467",
publisher = "Dove Medical Press Ltd.",
number = "1",

}

TY - JOUR

T1 - Surgical outcomes of the Ex-PRESS glaucoma filtration device in African American and white glaucoma patients

AU - Salim, Sarwat

AU - Du, Haiming

AU - Boonyaleephan, Sumalee

AU - Wan, Jim

PY - 2012/6/21

Y1 - 2012/6/21

N2 - Purpose: To compare the surgical outcomes of the Ex-PRESS glaucoma filtration device in African American and white glaucoma patients. Design: Retrospective comparative case series. Methods: This was a comparative case series of 36 eyes of 36 African Americans and 43 eyes of 43 whites that underwent placement of the Ex-PRESS glaucoma filtration device under a partial-thickness scleral flap for uncontrolled glaucoma. All eyes received intraoperative mitomycin C. The primary outcome measures were intraocular pressure (IOP), number of postoperative glaucoma medications, and surgical success. Surgical success was defined as IOP between 5 and 18 mm Hg, with or without glaucoma medications, without further glaucoma surgery, or loss of light perception vision. Results: Average follow-up was 31.9 ± 9.8 (range, 14.6-47) months for African Americans and 30.7 ± 8.6 (range, 14.3-47) months for whites. At 33 months, surgical success was 80.0% in the African American group and 83.3% in the white group (P = 1.00). Reasons for surgical failure included increased IOP (3 eyes, 3.8%), persistent hypotony with maculopathy (1 eye, 1.3%), and further surgery (4 eyes, 5.06%). Compared with preoperative values, the mean postoperative IOP and number of glaucoma medications were significantly reduced in both groups, and no statistical difference was observed between the two groups at 33 months. Postoperative complications were similar in the two groups. Conclusions: Similar surgical outcomes were observed in African American and white glaucoma patients after implantation of the Ex-PRESS glaucoma filtration device. This latest modification of glaucoma filtration surgery may be a better surgical option for African Americans given its potential advantages of no tissue removal, predictable outcomes related to consistent lumen size and controlled flow, fewer postoperative complications, and overall reduced inflammation.

AB - Purpose: To compare the surgical outcomes of the Ex-PRESS glaucoma filtration device in African American and white glaucoma patients. Design: Retrospective comparative case series. Methods: This was a comparative case series of 36 eyes of 36 African Americans and 43 eyes of 43 whites that underwent placement of the Ex-PRESS glaucoma filtration device under a partial-thickness scleral flap for uncontrolled glaucoma. All eyes received intraoperative mitomycin C. The primary outcome measures were intraocular pressure (IOP), number of postoperative glaucoma medications, and surgical success. Surgical success was defined as IOP between 5 and 18 mm Hg, with or without glaucoma medications, without further glaucoma surgery, or loss of light perception vision. Results: Average follow-up was 31.9 ± 9.8 (range, 14.6-47) months for African Americans and 30.7 ± 8.6 (range, 14.3-47) months for whites. At 33 months, surgical success was 80.0% in the African American group and 83.3% in the white group (P = 1.00). Reasons for surgical failure included increased IOP (3 eyes, 3.8%), persistent hypotony with maculopathy (1 eye, 1.3%), and further surgery (4 eyes, 5.06%). Compared with preoperative values, the mean postoperative IOP and number of glaucoma medications were significantly reduced in both groups, and no statistical difference was observed between the two groups at 33 months. Postoperative complications were similar in the two groups. Conclusions: Similar surgical outcomes were observed in African American and white glaucoma patients after implantation of the Ex-PRESS glaucoma filtration device. This latest modification of glaucoma filtration surgery may be a better surgical option for African Americans given its potential advantages of no tissue removal, predictable outcomes related to consistent lumen size and controlled flow, fewer postoperative complications, and overall reduced inflammation.

UR - http://www.scopus.com/inward/record.url?scp=84863476777&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863476777&partnerID=8YFLogxK

U2 - 10.2147/OPTH.S32282

DO - 10.2147/OPTH.S32282

M3 - Article

VL - 6

SP - 955

EP - 962

JO - Clinical Ophthalmology

JF - Clinical Ophthalmology

SN - 1177-5467

IS - 1

ER -